WILMINGTON, N.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- SportGait, the brain wellness and medical technology company, proudly announced today the publication of an article in the Journal of Concussion validating that its patented gait technology can create biomarkers to identify and manage neurological conditions. The first-of-its-kind study tested the reliability and accuracy of accelerometer-based gait assessment data. The study found that SportGait's BKG gait method and algorithms are superior in accuracy and usability for measuring and managing concussion outcomes.

"My core hypothesis is that the way we move through space reflects our overall health status. The BKG can be used as a biomarker of disease because each condition has a characteristic biokinetic signature," said Dr. Mark Williams, MD and BKG Innovator. "I created the BKG measuring other neurological conditions like Parkinson's Disease and Stroke, and I suspected that its application for mild traumatic brain injury would be equally as effective."

In the study, data collected by the accelerometer was used to create BioKinetoGraphs (BKGTM), which are a visual depiction of a person's gait. Like the shape of an EKG waveform, the graph-like displays visually correspond to different events during a gait cycle such as the heal striking the ground or the toe pushing off of it.  

"Physical, and in this case gait, biomarkers are becoming a critical component for healthcare," commented SportGait President and CEO Chris Newton. "Our team has worked tirelessly to create reliable and valid assessments and when you start looking at concussion, gait and balance are critical to measure. Our goal is to provide invaluable patient data to doctors who can use this information to improve care and, ultimately, health outcomes."

The research article was published in the Journal of Concussion in February 2023, and appears in Volume 7: 1-11. #" Featured Image for SportGait Featured Image for SportGait